Gyre Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GYRE | GPCR | GNFT.PA | VCRE | IVA | ANNX | |
|---|---|---|---|---|---|---|
| Market cap | 470.79M | 1.45B | 574.36M | 265.87M | 914.17M | 820.88M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 74.0 | -9.6 | 63.8 | — | -5.2 | -4.0 |
| Price/book | 4.4 | 1.1 | -11.8 | — | 13.8 | 4.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −39.92% | −39.17% | +218.29% | −41.91% | −7.42% | +43.38% |
| Today | 0.00% | +0.05% | +3.04% | +1.18% | −3.97% | +3.34% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GYRE news ›GSK (NYSE:GSK) versus Gyre Therapeutics (NASDAQ:GYRE) Financial Contrast
Posted by Kim Johansen on Oct 15th, 2026 GSK (NYSE:GSK – Get Free Report) and Gyre Therapeutics (NASDAQ:GYRE – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on…
Contrasting Scienture (NASDAQ:SCNX) & Gyre Therapeutics (NASDAQ:GYRE)
Posted by Mitch Edgeman on Oct 13th, 2026 Scienture (NASDAQ:SCNX – Get Free Report) and Gyre Therapeutics (NASDAQ:GYRE – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.